Comparative Study of Human Immunodeficiency Virus Negative Host Talaromyces Between Voriconazole and Amphotericin Sequential Itraconazole Therapy

Clinical trial NCT03827278 · UNKNOWN

Trial details

NCT number: NCT03827278
Sponsor: Guangxi Medical University
Status: UNKNOWN
Phase: Not Applicable
Study type: INTERVENTIONAL

Talaromyces in Human Immunodeficiency Virus Negative To Compare Voriconazole and Amphotericin Sequential Itraconazole Therapy To Dynamically Monitor the Anti-Interferon-γ Autoantibodies

Start date: 2018-12-30
Primary completion: 2021-12-30
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.